Stocks are at or near all-time highs as investors turn the page to December, and as far as investors are concerned, there appears to be no reason why they can’t go higher still.
Related Posts
Novo Nordisk’s next-gen obesity drug CagriSema had investors excited. Now they’re not so sure
Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt after a series of trial […]
OpenAI says Musk has run ‘unlawful campaign of harassment’ against company in lawsuit
OpenAI said in a lawsuit that Elon Musk made a “sham” attempt to buy the company, and asked a federal district court to stop him […]
Target will report earnings before the bell. Here’s what to expect
Target is trying to get back to growth as tariffs, economic uncertainty and company missteps dampen demand.